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Purpose: Our aim is to better understand the pathomolecular mecha-
nisms involved in OA. By studying molecular components across dif-
ferent OA joints we could perhaps understand the similarities,
disparities and identify key molecular mechanisms driving OA. High-
throughput comparative proteomics approaches offer a powerful
insight into the common and different molecules and their regulatory
mechanisms present in these two different OA joints.
Methods: Human cartilage samples obtained from carpometacarpal of
the thumb (CMC-I) and knee OA were immunostained for TLRs (1-9)
and analyzed using histomorphometry and principal component
analysis (PCA). mRNA was extracted and expression levels were ana-
lyzed by RT-PCR. Synovial ﬂuid (SF) was obtained from (CMC-I) OA
(n¼10) and knee OA (n¼10) patients. SF samples were albumin
depleted and analyzed in liquid mass spectrometry (LC/MS). Selected
molecules were validated by enzyme-linked immunosorbent assay
(ELISA).
Results: Contrary to the observed homogenous TLR expression in knee
OA (p<0.05), TLRs did not display grade-dependent overall proﬁle
changes in CMC-I OA, however PCA revealed that TLR expression
proﬁles clustered accordingly to their known cellular compartmen-
talization. We observed an atypical TLR4 expression at the mRNA
(increased) and protein level (decreased) in CMC-I OA cartilage in
comparison to equivalent-graded knee OA cartilage (data not shown).
This led us to believe that perhaps relevant molecules and regulatory
mechanism are differentially regulated between the two joints. SF
analysis with speciﬁc ELISAs for soluble biglycan (BGN) and soluble
toll-like receptor (TLR4) disclosed signiﬁcant differences on the pres-
ence of these catabolic and negative regulative molecules, respectively
(Figure 1).Figure 1. Box plot representation of soluble Biglycan and TLR4 Concen-
tration levels in synovial ﬂuid obtained from arthritic patients.
Our high-throughput approach by Comparative SF proteomic analysis
revealed that 120 commonly present proteins were differentially regu-
lated in knee and CMC-I joints, with 65 proteins being over expressed by
1.3 fold difference. In additionwe identiﬁed 41 newproteinswhich have
never been reported to be present in OA synovial ﬂuid. Bioinformatic
analysis of the differential regulated proteins reveal their signiﬁcant
participation in different molecular functions (Figure 2).Figure 2. Gene ontology analysis of differentially expressed proteins in
synovialﬂuid fromCMC-I and knee OA joints. (PANTHER analysis Pathway).
Conclusions: Our results from classical immunohistochemistry and
immunoassay techniques (IHC and ELISA) combined with forefront
Proteomics techniques (LC/MS) conﬁrm the differential expression of
several keymolecular players in CMC-I and knee OA. Taken together our
study trongly suggest that pathomolecular mechanisms of OA may
differ depending on the affected joint. The reported molecules are
putative biomarkers of OA and potential therapeutic targets for OA.
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PROGRANULIN PLAYS A CHONDROPROTECTIVE ROLE IN A
SURGICALLY-INDUCED OSTEOARTHRITIS IN MICE THROUGH TNFR2
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Purpose: Progranulin (PGRN) was previously reported as an osteo-
arthritis (OA)-associated growth factor. This study aims to investigate
the role of PGRN in the pathogenesis of OA in vivo.
Methods: Progression of OA was analyzed by surgically induced OA
models in wild type, PGRN-deﬁcient, TNFR1-deﬁcient and TNFR2-
deﬁcient mice. Cartilage degradation and OA severity were evaluated
using Safranin O and HE staining, immunohistochemistry and ELISA.
Additionally, mRNA expression of degenerative factors and catabolic
markers known to be involved in cartilage degeneration in OA were
analyzed.
Results: 1. Deﬁciency of PGRN leads to exaggerated osteoarthritis pro-
gression in destabilization of the medial meniscus mice model. To
determine the role of PGRN in the course of OA progression, we used a
surgically induced OA mice model, destabilization of the medial
meniscus(DMM) mice model in both wild type and PGRN-deﬁcient
mice. Safranin O staining revealed that more severe structure loss was
presented in PGRN-deﬁcient mice than in WT mice (Fig. 1A). Osteo-
arthritis Research Society International (OARSI) scoring of OA was
performed, and demonstrated that PGRN-deﬁcient mice had a sig-
niﬁcantly higher arthritic score than theWTgroup at all the time points
(Fig.1B). COMP degradation is widely used as a biomarker for OA pro-
gression COMP fragment-speciﬁc ELISA revealed that deﬁciency of
PGRN exaggerated degradation of COMP after DMM operation
(Fig. 1C).Additionally, synovium inﬂammation and osteophyte for-
mation of WT and PGRN/mice knee joint at 4 weeks after induction
were assayed through histology (Fig.1D), PGRN-deﬁcient mice pre-
sented markedly more severe synovium inﬂammation as well as
osteophyte formation compared with WT littermates. The immuno-
histochemistry staining demonstrated stronger positive signals for Col
X, MMP13 and COMP fragments in PGRN-deﬁcient group thanwild type
group at 8 weeks after DMM operation (Fig. 1E).
2. Recombinant PGRN protects against OA in anterior cruciate ligament
transection model through the TNFR2 pathway in vivo.
To investigate whether recombinant PGRN has a protective effect
against induction and development of OA, anterior cruciate ligament
transection(ACLT) model was established in wild type, TNFR1-deﬁcient
and TNFR2-deﬁcient mice (n¼7 for each group), followed by intra-
articular injection of phosphate buffered saline (PBS) or PGRN (6 mg)
once a week for 4 weeks. As shown in Fig.2A, surgically induced OA
caused destruction of articular cartilage in all three genotypes of mice
